Received Nov 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y010466 | — |
No additional AEs were reported; The healthcare worker is reporting that a patient received improperly stored vaccine; This spontaneous report was received from other health professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 21-May-2025, the patient was vaccinated with an improperly stored dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) suspension for injection, 1 dosage form, administered as prophylaxis (Lot No. Y010466 has been verified to be a valid lot number for [human papillomavirus 9-valent vaccine, recombinant], expiration date not reported, but upon internal validation established as 29-Oct-2026) (strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); after a temperature excursion of 31.3 degree Fahrenheit (F) during a time frame of 15 minutes. No previous temperature excursion was reported. No additional adverse events were reported (no adverse event). No further information provided.